AbCellera Biologics Inc. (ABCL) revenue

Revenue · fiscal 2025
$75.13M

AbCellera Biologics Inc. (ABCL) reported revenue of $75.13M in fiscal 2025 (the year ended December 31, 2025). That is 160.6% higher than the $28.83M of fiscal 2024. Figures as of 18 Nov 2026, 05:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$75.13M
Change on fiscal 2024
+160.6%
Growth, 5 years
−20.3% a year
Highest on record
$485.42Mfiscal 2022
Lowest on record
$11.61Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

AbCellera Biologics Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 20.3% a year. Across the 7 fiscal years on record (2019–2025), the highest was $485.42M in fiscal 2022 and the lowest $11.61M in fiscal 2019.

History · 7 fiscal years

Revenue by fiscal year

AbCellera Biologics Inc. revenue, year by year

AbCellera Biologics Inc. (ABCL) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$75.13M 160.6% up
2024$28.83M 24.2% down
2023$38.03M 92.2% down
2022$485.42M 29.4% up
2021$375.20M 60.9% up
2020$233.16M 1,907.9% up
2019$11.61M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on ABCL

AbCellera Biologics Inc., figure by figure

AbCellera Biologics Inc. (ABCL) overview: price, valuation and scorecard

AbCellera Biologics Inc. revenue: questions and answers

What is AbCellera Biologics Inc.'s revenue?

AbCellera Biologics Inc. (ABCL) reported revenue of $75.13M in fiscal 2025 (the year ended December 31, 2025). That is 160.6% higher than the $28.83M of fiscal 2024.

What is the growth rate of AbCellera Biologics Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 20.3% a year.

What are the highest and lowest revenue figures on record for AbCellera Biologics Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $485.42M in fiscal 2022 and the lowest $11.61M in fiscal 2019.

How is AbCellera Biologics Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AbCellera Biologics Inc. (ABCL) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ABCL/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.